All

× UPDATE! Updated as of 05 April 2024.
Records 201 to 220 of 32210
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Classification
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View BR-1354 Diphtheria-Tetanus Vaccine (Adsorbed, Reduced Antigen Content) BE Td Each dose (0.5 mL) contains: Diphtheria toxoid- 2 Lf (>2 IU) Tetanus toxoid- 8.8 Lf (>20 IU) Adsorbed on Aluminum Phosphate-> 1.5 mg Preservative: Thiomersal BP-0.01% w/v Solution For Injection (I.M) Prescription Drug (Rx) - Biological E. Limited India Initial 17 June 2021 17 June 2026
View BR-1352 Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) Combe Five Each dose (0.5 mL) contains: Diphtheria toxoid ................... 25 Lf ( > 30 IU) Tetanus toxoid ...................... 5.5 Lf (> 60 IU) B. pertussis (whole cell) ........... 16 IOU ( >4 IU) Hepatitis B (rDNA) ................ 12.5 ug Purified capsular polysaccharide (PRP) of Hib covalently linked to 20 to 36.7 ug of tetanus toxoid .... ............... 11 ug Alt+t (as AlPO4) ........ ............. <1.25 mg Thiomersal ............ ........... 0.01% w/v Solution For Injection (I.M) Prescription Drug (RX) - Biological E. Limited India - 08 June 2021 08 June 2026
View BR-1353 Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) Combe Five Each dose (0.5 mL) contains: Diphtheria toxoid 25 Lf 30 IU) Tetanus toxoid....................... 5.5 Lf 60 IU) B. pertussis (whole cell ............ 16 IOU ( 4 IU) Hepatitis B (rDNA)................12.5 ug Purified capsular polysaccharide (PRP) of Hib covalently linked to 20 to 36.7 ug of tetanus toxoid ..................11 ug Alt++ (as AlPO4)..................... 51.25 mg Thiomersal .......... 0.01% w/v Suspension for Injection (IM) Prescription Drug (RX) - Biological E. Limited India - 08 June 2021 08 June 2026
View BR-1355 Diphtheria-Tetanus Vaccine (Adsorbed, Reduced Antigen Content) BE Td Each dose (0.5 mL) contains: Diphtheria toxoid-2 Lf (>2 IU) Tetanus toxoid-8.8 Lf (>20 IU) Adsorbed on Aluminum Phosphate-> 1.5 mg Preservative: Thiomersal BP-0.01% w/v Suspension for Injection (IM) Prescription Drug (Rx) - Biological E. Limited India Initial 17 June 2021 17 June 2026
View BR-1360 Human Blood Coagulation Factor VIII Green-VIII Inj. 500 IU (25 IU/mL) Lyophilized Powder for Solution for Injection (IV) Prescription Drug (RX) - Green Cross Corp. Korea - 26 July 2021 26 July 2026
View BR-1361 Human Coagulation Factor VIII Green-VIII Inj. 250 IU (25 IU/mL) Lyophilized Powder for Solution for Injection (IV) Lyophilized Powder for Solution for Injection (IV) Prescription Drugs (RX) - Green Cross Corp. Korea - 26 July 2021 26 July 2026
View BR-1362 Atezolizumab Tecentriq 840mg/14mL(60mg/mL) Concentrate for Solution for IV Infusion Prescription Drug (Rx) - F. Hoffman-La Roche AG Switzerland Monitored Release 02 August 2021 02 August 2024
View BR-1363 Bacillus Calmette-Guerin (BCG) Vaccine None 0.5mg/1.0 mL Lyophilized Powder for Injection (ID) Prescription Drug (RX) - Institute of Vaccines and Medical Biologicals Vietnam Initial 05 August 2021 05 August 2026
View BR-1364 Insulin Aspart Novomix 30 Flexpen 100 U/mL (3.5 mg/mL) Suspension for Injection (SC) (30% Insulin Aspart and 70% Insulin Aspart Protamine) Prescription Drug (RX) - Novo Nordisk Production SAS France - 02 September 2021 02 September 2026
View BR-1365_PI_01.pdf BR-1365 Durvalumab Imfinzi 120 mg/2.4 mL (50 mg/mL) Cocentrate for Solution for IV Infusion Prescription Drug (RX) - Catalent Indiana, LLC United States of America Monitored Release (MR) 07 September 2021 07 September 2024
View BR-1366-PI_01.pdf BR-1366 Durvalumab Imfinzi 500 mg/10 mL (50 mg/mL) Cocentrate for Solution for IV Infusion Prescription Drug (RX) - Catalent Indiana, LLC United States of America Monitored Release (MR) 07 September 2021 07 September 2024
View BR-1367 Bovine Lung Surfactant Newfactan 120 mg Powder For Solution For Intratracheal Infusion Prescription Drug (Rx) - Yuhan Corporation korea Renewal (Revalidation) 21 March 2023 28 December 2024
View BR-1368 Human Normal Immunoglobulin Eugamma SN 10% Inj. 5000 mg/50 mL (100 mg/mL) Solution For Infusion IV Prescription Drug (RX) - Green Cross Corp. Korea - 08 September 2021 08 September 2026
View BR-1369 Insulin Aspart Novorapid Flexpen 100 units/mL (3.5mg/mL) Solution For Injection (IV/SC) Prescription Drug (RX) - Novo Nordisk Production SAS France - 14 September 2021 14 September 2026
View BR-1370 Tetanus Toxoid (Adsorbed) Abhay-TOX 40 IU/0.5mL Solution For Injection (IM) Prescription Drug (RX) - Human Biologicals Institute (A Division of Indian Immunologicals Limited) India - 16 September 2021 16 September 2026
View BR-1371 Insulin Human (rDNA) Mixtard 30 Flexpen 100 U/mL Suspension for Injection (SC) (30% Soluble Insulin and 70% Isophane Insulin) Prescription Drug (RX) - Novo Nordisk Produção Farmacêutica do Brasil Ltda. Brazil Initial 24 September 2021 24 September 2026
View BR-1372_PI_01.pdf BR-1372 Somatropin Norditropin Nordiflex 5 mg / 1.5mL Solution For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 06 October 2021 06 October 2026
View BR-1373_PI_01.pdf BR-1373 Somatropin Norditropin Nordiflex 10 mg/ 1.5mL Solution For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 06 October 2021 06 October 2026
View BR-1374_PI_01.pdf BR-1374 Somatropin Norditropin Nordiflex 15 mg/1.5mL Solution For Injection (SC) Prescription Drug (RX) - Novo Nordisk A/S Denmark - 06 October 2021 06 October 2026
View BR-1375 Bevacizumab Zirabev 100 mg/4 mL (25 mg/mL) Concentrate For Solution For I.V. Injection Prescription Drug (RX) - Pharmacia and Upjohn Company LLC United States of America Initial 19 October 2021 19 October 2026